Alert: Hydroxycut Lawsuits Have Already Been Registered
On May 1, 2009, there had been a recall of fourteen Hydroxycut diet-aid products springing from a number of reports that people using the products were developing significant liver problems and other health worries. Less than 7 days later, on May 4, the first Hydroxycut class action suit was filed against the company that manufactures the products, Iovate Medical Sciences. The Hydroxycut Class Action Lawsuit alleges company failure in informing the public about potential risks of the products. Naturally, it’s too shortly to understand the suit is going to turn out, but if the company had information which it did not reveal to buyers, it should definitely be held accountable.
A class action court action is filed by a group of folk, all of whom have similar claims against a certain company. Filing a class action is just as effective, and much less pricey, than filing an individual suit. As a rule, filing a class action lawsuit won’t cost you anything unless there’s a settlement. At that point, the attorney who handled the suit will take his fees from the compensation that was given and then distribute the leftover funds to the accusers in the case. Since this is the case, you’ll be able to file a Hydroxycut class action suit without paying a penny out of your own pocket, which is one of the explanations that class action suits became so popular.
The initial class action legal action against Iovate was filed in Canada where the company is located and represents all Canadian citizens who sustained health problems due to Hydroxycut products. The FDA recall happened in the U. S. where 23 cases of liver disorders and other health problems had been reported. Health Canada did not receive any reports of liver damage due to the diet products, but they did receive seventeen reports concerning people who sustained breathing, neurological, cardio, and gut problems as a result of Canadians using the products.
The Hydroxycut Liver Damage Suits alleges the company sold the company sold the general public of the public of the health risks that they could exposing patrons to. The complaint states that the company did not publish the data on the product labels stating that users could run the danger of liver and kidney damage as well as gastrointestinal, cardiovascular, respiratory, and neurological issues. The suit goes on to claim this was a blatant omission on the part of the company which purposely misled clients concerning the safety of the products.
